Case number 1:20-cv-00277
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 10, 2020 | N/A | Terminated Case (0) Docket Text: CASES CLOSED per the entry of the Consent Judgment in Lead Case No. 18-1689-CFC. Associated Cases: 1:18-cv-01786-CFC-SRF, 1:19-cv-01594-CFC, 1:20-cv-00277-CFC(nmf) |
| May 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (9 in 1:20-cv-00277-CFC, 248 in 1:18-cv-01689-CFC-SRF) STIPULATION AND ORDER OF CONSOLIDATION. Signed by Judge Colm F. Connolly on 5/5/2020. Associated Cases: 1:18-cv-01689-CFC-SRF, 1:20-cv-00277-CFC(nmf) |
| May 5, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01689-CFC-SRF. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-1689-CFC ONLY. (nmf) |
| May 5, 2020 | 9 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Apr 27, 2020 | 8 | Answer to Complaint (20) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Annora Pharma Private Limited, Hetero USA Inc.,.(Harmon, Kate) |
| Mar 4, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Feb 27, 2020 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Annora Pharma Private Limited served on 2/26/2020, answer due 3/18/2020. (Egan, Brian) |
| Feb 27, 2020 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Hetero USA Inc., served on 2/26/2020, answer due 3/18/2020. (Egan, Brian) |
| Feb 26, 2020 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Annora Pharma Private Limited on 2/26/2020; Hetero USA Inc., on 2/26/2020. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam) |
| Feb 25, 2020 | 1 | Exhibit 1 (48) |
| Feb 25, 2020 | 1 | Civil Cover Sheet (1) |
| Feb 25, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Feb 25, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 01/09/2020. Date of Expiration of Patent: 04/03/2034.Thirty Month Stay Deadline: 02/01/2022. (sam) |
| Feb 25, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number 10,258,637 B2. (sam) |
| Feb 25, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Pharmaceuticals Inc. -filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (sam) |
| Feb 25, 2020 | 1 | Complaint* (1) |
